Skip to main content
Top
Published in: Clinical and Molecular Allergy 1/2012

Open Access 01-12-2012 | Research

IL-3 and TNFα increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation

Authors: Ellen B Cook, James L Stahl, Elizabeth A Schwantes, Kristen E Fox, Sameer K Mathur

Published in: Clinical and Molecular Allergy | Issue 1/2012

Login to get access

Abstract

Background

Thymic stromal lymphopoietin (TSLP) and eosinophils are prominent components of allergic inflammation. Therefore, we sought to determine whether TSLP could activate eosinophils, focusing on measuring the regulation of TSLPR expression on eosinophils and degranulation in response to TSLP, as well as other eosinophil activation responses.

Methods

Eosinophil mRNA expression of TSLPR and IL-7Rα was examined by real-time quantitative PCR of human eosinophils treated with TNFα and IL-5 family cytokines, and TSLPR surface expression on eosinophils was analyzed by flow cytometry. Eosinophils were stimulated with TSLP (with and without pre-activation with TNFα and IL-3) and evaluated for release of eosinophil derived neurotoxin (EDN), phosphorylation of STAT5, and survival by trypan blue exclusion. A blocking antibody for TSLPR was used to confirm the specificity of TSLP mediated signaling on eosinophil degranulation.

Results

Eosinophil expression of cell surface TSLPR and TSLPR mRNA was upregulated by stimulation with TNFα and IL-3. TSLP stimulation resulted in release of EDN, phosphorylation of STAT5 as well as promotion of viability and survival. TSLP-stimulated eosinophil degranulation was inhibited by a functional blocking antibody to TSLPR. Pre-activation of eosinophils with TNFα and IL-3 promoted eosinophil degranulation at lower concentrations of TSLP stimulation.

Conclusions

This study demonstrates that eosinophils are activated by TSLP and that eosinophil degranulation in response to TSLP may be enhanced on exposure to cytokines present in allergic inflammation, indicating that the eosinophil has the capacity to participate in TSLP-driven allergic responses.
Appendix
Available only for authorised users
Literature
1.
go back to reference Holgate ST: The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol. 2007, 28: 248-251. 10.1016/j.it.2007.04.007CrossRefPubMed Holgate ST: The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol. 2007, 28: 248-251. 10.1016/j.it.2007.04.007CrossRefPubMed
2.
3.
go back to reference Mou Z, Xia J, Tan Y, Wang X, Zhang Y, Zhou B, Li H, Han D: Overexpression of thymic stromal lymphopoietin in allergic rhinitis. Acta Otolaryngol. 2009, 129: 297-301. 10.1080/00016480802225884CrossRefPubMed Mou Z, Xia J, Tan Y, Wang X, Zhang Y, Zhou B, Li H, Han D: Overexpression of thymic stromal lymphopoietin in allergic rhinitis. Acta Otolaryngol. 2009, 129: 297-301. 10.1080/00016480802225884CrossRefPubMed
4.
go back to reference Kimura S, Pawankar R, Mori S, Nonaka M, Masuno S, Yagi T, Okubo K: Increased expression and role of thymic stromal lymphopoietin in nasal polyposis. Allergy Asthma Immunol Res. 2011, 3: 186-193. 10.4168/aair.2011.3.3.186PubMedCentralCrossRefPubMed Kimura S, Pawankar R, Mori S, Nonaka M, Masuno S, Yagi T, Okubo K: Increased expression and role of thymic stromal lymphopoietin in nasal polyposis. Allergy Asthma Immunol Res. 2011, 3: 186-193. 10.4168/aair.2011.3.3.186PubMedCentralCrossRefPubMed
5.
go back to reference Matsuda A, Ebihara N, Yokoi N, Kawasaki S, Tanioka H, Inatomi T, de Waal MR, Hamuro J, Kinoshita S, Murakami A: Functional role of thymic stromal lymphopoietin in chronic allergic keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2010, 51: 151-155. 10.1167/iovs.09-4183CrossRefPubMed Matsuda A, Ebihara N, Yokoi N, Kawasaki S, Tanioka H, Inatomi T, de Waal MR, Hamuro J, Kinoshita S, Murakami A: Functional role of thymic stromal lymphopoietin in chronic allergic keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2010, 51: 151-155. 10.1167/iovs.09-4183CrossRefPubMed
6.
go back to reference Roan F, Bell BD, Stoklasek TA, Kitajima M, Han H, Ziegler SF: The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond. J Leukoc Biol. 2012, 91: 877-886. 10.1189/jlb.1211622PubMedCentralCrossRefPubMed Roan F, Bell BD, Stoklasek TA, Kitajima M, Han H, Ziegler SF: The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond. J Leukoc Biol. 2012, 91: 877-886. 10.1189/jlb.1211622PubMedCentralCrossRefPubMed
7.
go back to reference Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, Waal-Malefyt R, Bazan F, Kastelein RA, Liu YJ: Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol. 2002, 3: 673-680. 10.1038/nrm910CrossRefPubMed Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, Waal-Malefyt R, Bazan F, Kastelein RA, Liu YJ: Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol. 2002, 3: 673-680. 10.1038/nrm910CrossRefPubMed
8.
go back to reference Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N, Qin FXF, Yao ZB, Cao W, Liu YJ: TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med. 2005, 202: 1213-1223. 10.1084/jem.20051135PubMedCentralCrossRefPubMed Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N, Qin FXF, Yao ZB, Cao W, Liu YJ: TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med. 2005, 202: 1213-1223. 10.1084/jem.20051135PubMedCentralCrossRefPubMed
9.
go back to reference Rochman I, Watanabe N, Arima K, Liu YJ, Leonard WJ: Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4(+) T cells. J Immunol. 2007, 178: 6720-6724.CrossRefPubMed Rochman I, Watanabe N, Arima K, Liu YJ, Leonard WJ: Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4(+) T cells. J Immunol. 2007, 178: 6720-6724.CrossRefPubMed
10.
go back to reference Allakhverdi Z, Comeau MR, Jessup HK, Yoon BRP, Brewer A, Chartier S, Paquette N, Ziegler SF, Sarfati M, Delespesse G: Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med. 2007, 204: 253-258. 10.1084/jem.20062211PubMedCentralCrossRefPubMed Allakhverdi Z, Comeau MR, Jessup HK, Yoon BRP, Brewer A, Chartier S, Paquette N, Ziegler SF, Sarfati M, Delespesse G: Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med. 2007, 204: 253-258. 10.1084/jem.20062211PubMedCentralCrossRefPubMed
11.
go back to reference Wong CK, Hu S, Cheung PFY, Lam CW: TSLP induces chemotactic and pro-survival effects in eosinophils: implications in allergic inflammation. Am J Respir Cell Mol Biol. 2010, 43: 305-315. 10.1165/rcmb.2009-0168OCCrossRefPubMed Wong CK, Hu S, Cheung PFY, Lam CW: TSLP induces chemotactic and pro-survival effects in eosinophils: implications in allergic inflammation. Am J Respir Cell Mol Biol. 2010, 43: 305-315. 10.1165/rcmb.2009-0168OCCrossRefPubMed
12.
13.
go back to reference Reefer AJ, Hulse KE, Lannigan JA, Solga MD, Wright PW, Kelly LA, Patrie J, Chapman MD, Woodfolk JA: Flow cytometry imaging identifies rare T(H)2 cells expressing thymic stromal lymphopoietin receptor in a “proallergic” milieu. J Allergy Clin Immunol. 2010, 126: 1049-1058. 10.1016/j.jaci.2010.07.023PubMedCentralCrossRefPubMed Reefer AJ, Hulse KE, Lannigan JA, Solga MD, Wright PW, Kelly LA, Patrie J, Chapman MD, Woodfolk JA: Flow cytometry imaging identifies rare T(H)2 cells expressing thymic stromal lymphopoietin receptor in a “proallergic” milieu. J Allergy Clin Immunol. 2010, 126: 1049-1058. 10.1016/j.jaci.2010.07.023PubMedCentralCrossRefPubMed
14.
go back to reference Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME: Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008, 38: 709-750. 10.1111/j.1365-2222.2008.02958.xCrossRefPubMed Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME: Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008, 38: 709-750. 10.1111/j.1365-2222.2008.02958.xCrossRefPubMed
15.
go back to reference Kelly EAB, Koziol-White CJ, Clay KJ, Liu LY, Bates ME, Bertics PJ, Jarjour NN: Potential contribution of IL-7 to allergen-induced eosinophilic airway inflammation in asthma. J Immunol. 2009, 182: 1404-1410.PubMedCentralCrossRefPubMed Kelly EAB, Koziol-White CJ, Clay KJ, Liu LY, Bates ME, Bertics PJ, Jarjour NN: Potential contribution of IL-7 to allergen-induced eosinophilic airway inflammation in asthma. J Immunol. 2009, 182: 1404-1410.PubMedCentralCrossRefPubMed
16.
go back to reference Cook EB, Stahl JL, Sedgwick JB, Barney NP, Graziano FM: The promotion of eosinophil degranulation and adhesion to conjunctival epithelial cells by IgE-activated conjunctival mast cells. Ann Allergy Asthma Immunol. 2004, 92: 65-72. 10.1016/S1081-1206(10)61712-7CrossRefPubMed Cook EB, Stahl JL, Sedgwick JB, Barney NP, Graziano FM: The promotion of eosinophil degranulation and adhesion to conjunctival epithelial cells by IgE-activated conjunctival mast cells. Ann Allergy Asthma Immunol. 2004, 92: 65-72. 10.1016/S1081-1206(10)61712-7CrossRefPubMed
17.
go back to reference Sedgwick JB, Calhoun WJ, Vrtis RF, Bates ME, Mcallister PK, Busse WW: Comparison of airway and blood eosinophil function after invivo antigen challenge. J Immunol. 1992, 149: 3710-3718.PubMed Sedgwick JB, Calhoun WJ, Vrtis RF, Bates ME, Mcallister PK, Busse WW: Comparison of airway and blood eosinophil function after invivo antigen challenge. J Immunol. 1992, 149: 3710-3718.PubMed
18.
go back to reference Sedgwick JB, Vrtis RF, Gourley MF, Busse WW: Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol. 1988, 81: 876-883. 10.1016/0091-6749(88)90945-1CrossRefPubMed Sedgwick JB, Vrtis RF, Gourley MF, Busse WW: Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol. 1988, 81: 876-883. 10.1016/0091-6749(88)90945-1CrossRefPubMed
19.
go back to reference Sedgwick JB, Hwang YS, Gerbyshak HA, Kita H, Busse WW: Oxidized low-density lipoprotein activates migration and degranulation of human granulocytes. Am J Respir Cell Mol Biol. 2003, 29: 702-709. 10.1165/rcmb.2002-0257OCCrossRefPubMed Sedgwick JB, Hwang YS, Gerbyshak HA, Kita H, Busse WW: Oxidized low-density lipoprotein activates migration and degranulation of human granulocytes. Am J Respir Cell Mol Biol. 2003, 29: 702-709. 10.1165/rcmb.2002-0257OCCrossRefPubMed
20.
go back to reference Stout BA, Bates ME, Liu LY, Farrington NN, Bertics PJ: IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote pim-1 and cyclin D3 protein expression in human eosinophils. J Immunol. 2004, 173: 6409-6417.CrossRefPubMed Stout BA, Bates ME, Liu LY, Farrington NN, Bertics PJ: IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote pim-1 and cyclin D3 protein expression in human eosinophils. J Immunol. 2004, 173: 6409-6417.CrossRefPubMed
21.
go back to reference Rothenberg ME, Owen WF, Silberstein DS, Woods J, Soberman RJ, Austen KF, Stevens RL: Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest. 1988, 81: 1986-1992. 10.1172/JCI113547PubMedCentralCrossRefPubMed Rothenberg ME, Owen WF, Silberstein DS, Woods J, Soberman RJ, Austen KF, Stevens RL: Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest. 1988, 81: 1986-1992. 10.1172/JCI113547PubMedCentralCrossRefPubMed
22.
go back to reference Zhu Y, Bertics PJ: Chemoattractant-induced signaling via the Ras−ERK and PI3K−Akt networks, along with leukotriene C4 release, is dependent on the tyrosine kinase Lyn in IL-5− and IL-3−primed human blood eosinophils. J Immunol. 2011, 186: 516-526. 10.4049/jimmunol.1000955PubMedCentralCrossRefPubMed Zhu Y, Bertics PJ: Chemoattractant-induced signaling via the Ras−ERK and PI3K−Akt networks, along with leukotriene C4 release, is dependent on the tyrosine kinase Lyn in IL-5− and IL-3−primed human blood eosinophils. J Immunol. 2011, 186: 516-526. 10.4049/jimmunol.1000955PubMedCentralCrossRefPubMed
23.
go back to reference Luijk B, Lindemans CA, Kanters D, van der HR, Bertics P, Lammers JW, Bates ME, Koenderman L: Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge. J Allergy Clin Immunol. 2005, 115: 997-1003. 10.1016/j.jaci.2005.02.002CrossRefPubMed Luijk B, Lindemans CA, Kanters D, van der HR, Bertics P, Lammers JW, Bates ME, Koenderman L: Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge. J Allergy Clin Immunol. 2005, 115: 997-1003. 10.1016/j.jaci.2005.02.002CrossRefPubMed
24.
go back to reference Sedgwick JB, Vrtis RF, Jansen KJ, Kita H, Bartemes K, Busse WW: Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol. 2004, 114: 568-574. 10.1016/j.jaci.2004.05.023CrossRefPubMed Sedgwick JB, Vrtis RF, Jansen KJ, Kita H, Bartemes K, Busse WW: Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol. 2004, 114: 568-574. 10.1016/j.jaci.2004.05.023CrossRefPubMed
25.
go back to reference Jessup HK, Brewer AW, Omori M, Rickel EA, Budelsky AL, Yoon BRP, Ziegler SF, Comeau MR: Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response. J Immunol. 2008, 181: 4311-4319.CrossRefPubMed Jessup HK, Brewer AW, Omori M, Rickel EA, Budelsky AL, Yoon BRP, Ziegler SF, Comeau MR: Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response. J Immunol. 2008, 181: 4311-4319.CrossRefPubMed
26.
go back to reference Demehri S, Morimoto M, Holtzman MJ, Kopan R: Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. Plos Biology. 2009, 7 (85): E1000067. 10.1371/journal.pbio.1000067PubMedCentralCrossRefPubMed Demehri S, Morimoto M, Holtzman MJ, Kopan R: Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. Plos Biology. 2009, 7 (85): E1000067. 10.1371/journal.pbio.1000067PubMedCentralCrossRefPubMed
Metadata
Title
IL-3 and TNFα increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation
Authors
Ellen B Cook
James L Stahl
Elizabeth A Schwantes
Kristen E Fox
Sameer K Mathur
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Clinical and Molecular Allergy / Issue 1/2012
Electronic ISSN: 1476-7961
DOI
https://doi.org/10.1186/1476-7961-10-8

Other articles of this Issue 1/2012

Clinical and Molecular Allergy 1/2012 Go to the issue